CEL-SCI CORPORATION Total Liabilities and Equity
CEL-SCI CORPORATION (CVM) had Total Liabilities and Equity of $21.36 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $21.36M.
- 2026-03-31: Liabilities and Equity $17.71M.
- 2025-12-31: Liabilities and Equity $22.89M.
- 2025-09-30: Liabilities and Equity $28.16M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $21.36M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $17.71M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $22.89M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $28.16M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $20.34M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $21.81M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $25.70M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $26.99M 10-K · filed 2025-12-29 | |
| 2024-06-30 | $24.07M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $30.05M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $28.71M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $30.53M 10-K · filed 2025-01-13 | |
| 2023-06-30 | $32.32M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $38.20M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $44.56M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $50.52M 10-K · filed 2023-12-21 | |
| 2022-06-30 | $56.89M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $64.16M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $69.67M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $75.87M 10-K · filed 2022-12-27 | |
| 2021-06-30 | $79.64M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $48.37M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $49.61M 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $40.54M 10-K · filed 2021-12-21 | |
| 2020-06-30 | $43.91M 10-Q/A · filed 2020-12-31 | $42.03M 10-Q/A · filed 2020-08-11 |
| 2020-03-31 | $36.65M 10-Q/A · filed 2020-12-30 | $34.72M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $31.49M 10-Q/A · filed 2020-12-30 | $29.51M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $27.62M 10-Q/A · filed 2020-12-31 | |
| 2019-06-30 | $28.48M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $24.76M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $25.93M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $29.59M 10-K/A · filed 2019-12-23 | |
| 2018-06-30 | $21.70M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $23.09M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $22.17M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $22.92M 10-K · filed 2018-12-19 | |
| 2017-06-30 | $21.82M 10-Q/A · filed 2017-12-11 | $8.44M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $22.08M 10-Q/A · filed 2017-12-11 | $8.73M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $23.25M 10-Q/A · filed 2017-12-11 | $9.93M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $24.89M 10-K · filed 2017-12-29 | $11.60M 10-K · filed 2016-12-15 |
| 2016-06-30 | $14.48M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $15.52M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $19.98M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $28.55M 10-K/A · filed 2017-12-11 | $15.45M 10-K · filed 2015-12-11 |
| 2015-06-30 | $21.50M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $12.73M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $19.55M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $19.23M 10-K · filed 2015-12-11 | |
| 2014-06-30 | $25.16M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $21.82M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $24.80M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $10.84M 10-K · filed 2014-12-23 | |
| 2013-06-30 | $14.75M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $18.49M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $22.01M 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $16.07M 10-K · filed 2013-12-27 | |
| 2012-06-30 | $19.93M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $18.38M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $16.68M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $18.63M 10-K · filed 2012-12-14 | |
| 2011-06-30 | $23.74M 10-Q · filed 2011-08-09 | |
| 2010-09-30 | $37.80M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |